BIOMAT Database Logo BIOMAT Database Logo

[Surgical treatment of stage IIIA non-small-cell lung cancer]. 2000

V A Porkhanov, and V S Mova, and V B Kononenko, and V N Bodnia, and I S Poliakov
Clinic of Thoracic Surgery, Municipal Diagnostic Center, Krasnodar.

Data on five-year survival were evaluated for 258 patients with non-small cell lung cancer (stage IIIA) (N2). In 155 patients (60%), N2 tumor was detected during surgery. Total resection was carried out in 179 (69.4%), subtotal--79 (30.6%). Total lymph node dissection was not employed in the latter group. Lateral thoracotomy was used in 213 cases. Transsternal procedure was performed in 45 cases of bulky tumor and extensive invasion of mediastinal fat. A comparison of five-year survival data failed to establish any relationship between survival and postoperative radiochemotherapy in radically-operated patients. It was found that surgery for non-small lung N2 tumors with mediastinal involvement is indicated and may be effective if total lymph node dissection is performed.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008197 Lymph Node Excision Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966) Lymph Node Dissection,Lymphadenectomy,Dissection, Lymph Node,Dissections, Lymph Node,Excision, Lymph Node,Excisions, Lymph Node,Lymph Node Dissections,Lymph Node Excisions,Lymphadenectomies,Node Dissection, Lymph,Node Dissections, Lymph
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

V A Porkhanov, and V S Mova, and V B Kononenko, and V N Bodnia, and I S Poliakov
Results of surgical treatment of stage IIIA non-small cell lung cancer.
January 1995, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,
V A Porkhanov, and V S Mova, and V B Kononenko, and V N Bodnia, and I S Poliakov
Surgical Management of Stage IIIA Non-Small Cell Lung Cancer.
January 2017, Frontiers in oncology,
V A Porkhanov, and V S Mova, and V B Kononenko, and V N Bodnia, and I S Poliakov
Treatment of stage IIIA non-small cell lung cancer.
January 2003, Chest,
V A Porkhanov, and V S Mova, and V B Kononenko, and V N Bodnia, and I S Poliakov
Surgical approach to non-small cell lung cancer stage IIIA.
December 1990, Hematology/oncology clinics of North America,
V A Porkhanov, and V S Mova, and V B Kononenko, and V N Bodnia, and I S Poliakov
Multidisciplinary Treatment of Stage IIIA Non-Small-Cell Lung Cancer.
July 2016, Journal of oncology practice,
V A Porkhanov, and V S Mova, and V B Kononenko, and V N Bodnia, and I S Poliakov
Treatment of resectable stage IIIA non-small cell lung cancer.
January 2017, Journal of thoracic disease,
V A Porkhanov, and V S Mova, and V B Kononenko, and V N Bodnia, and I S Poliakov
Results of surgical treatment in patients with stage IIIA non-small-cell lung cancer.
February 1991, The Thoracic and cardiovascular surgeon,
V A Porkhanov, and V S Mova, and V B Kononenko, and V N Bodnia, and I S Poliakov
Surgical challenges in multimodal treatment of N2-stage IIIA non-small cell lung cancer.
March 2021, Japanese journal of clinical oncology,
V A Porkhanov, and V S Mova, and V B Kononenko, and V N Bodnia, and I S Poliakov
Current surgical therapy for stage IIIA (N2) non-small cell lung cancer.
January 2011, Seminars in thoracic and cardiovascular surgery,
V A Porkhanov, and V S Mova, and V B Kononenko, and V N Bodnia, and I S Poliakov
Multimodality treatment of stage IIIA and IIIB non-small cell lung cancer.
May 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer,
Copied contents to your clipboard!